Common Contracts

2 similar Agreement and Plan of Merger contracts by Seneca Biopharma, Inc., Vallon Pharmaceuticals, Inc.

AGREEMENT AND PLAN OF MERGER among: VALLON PHARMACEUTICALS, INC.; VALLON MERGER SUB, INC.; and GRI BIO, INC. Dated as of December 13, 2022
Agreement and Plan of Merger • December 13th, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of December 13, 2022, by and among VALLON PHARMACEUTICALS, INC., a Delaware corporation (“PubCo”), VALLON MERGER SUB, INC., a Delaware corporation and wholly owned Subsidiary of PubCo (“Merger Sub”), and GRI BIO, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1.

AutoNDA by SimpleDocs
AGREEMENT AND PLAN OF MERGER among: SENECA BIOPHARMA INC.; TOWNSGATE ACQUISITION SUB 1, INC.; and LEADING BIOSCIENCES, INC. Dated as of December 16, 2020
Agreement and Plan of Merger • December 21st, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware

This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of December 16, 2020, by and among Seneca Biopharma, Inc., a Delaware corporation (“PubCo”), Townsgate Acquisition Sub 1, Inc., a Delaware corporation and wholly owned Subsidiary of PubCo (“Merger Sub”), and Leading BioSciences, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!